Behavioral and Functional Neuroscience Laboratory
Message from the director Dr. Mehrdad shamloo

As part of the Stanford Neurosciences Institute, BFNL provides  a preclinical discovery platform for CNS target validation in preclinical in vivo and in vitro models. Our well validated neurobehavioral assessment tools in CNS disease models provide a unique platform for the screening and profiling of experimental therapeutics and genetic rodent models. We aim to accelerate the progress in both fundamental and applied studies of nervous system function. We collaborate with academic laboratories, non-profit foundations, and biopharmaceutical companies worldwide to support the understanding of human CNS disorders and develop therapeutic interventions. Our overarching goal is to lead and enable translation of scientific discoveries into novel therapeutic approaches that improve the quality of life for patients with disorders of the brain and spinal cord.  Our disease models focus includes: cognition and memory, pain, stroke, spinal cord injury, Alzheimer’s disease, Down syndrome, Huntington’s disease, ALS, Autism Spectrum Disorder, and Schizophrenia, as well as social interaction.

BEHAVIORAL PHENOTYPING AND NEUROPHARMALOGICAL CAPABILITIES
Lab Reservation
Collaborations and Services
Featured Test
News
   

Stanford Medicine Resources:

Footer Links: